Reviva Pharmaceuticals Hldg Inc

-0.028 (6.53%)
NASDAQ (OPEN)

Reviva Pharmaceuticals Hldg Inc (RVPH) @ NASDAQ

Printed Wednesday, 4 November '26 13:00 ADT

Description: Reviva Pharmaceuticals Inc. is a clinical stage pharmaceutical company. It engages in developing therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic and inflammatory diseases. The company's lead product candidate includes RP5063, for the treatment of schizophrenia, bipolar disorder and major depressive disorder. Reviva Pharmaceuticals Inc., formerly known as Tenzing Acquisition Corp., is based in NEW YORK.

Biotechnology Common Stock β +0.48

Attributes Seasonality Filters
Date Name (*Public) Description Symbol Type Size Action
Date Value Error Logarithmic Error Model (*Public)
-$0.028 (6.53%) on Tuesday, 3 November 2026, Marketcap $5.14 M
Date Value Δ Open Close Low High Adjusted Volume Δ
Name Version (*Public) Indicator % Auto Description Symbol Company Name Forecasts Buy / Sell Action
Opened (Closed) Expires Symbol Company Name Name (*Public) Size Contract Symbol Open P/L Close P/L Total P/L ROI DTE DIT Delta Action
Details Best Trend by Hindsight Forecast Profit or Loss
Date (*Public) Symbol Strategy Data Origin Slope Sigma Cor % Moves Sigma Moves Gain % Periods Action
Date Name (*Public) Description Price Quantity Total Cost Type Symbol Action
Date RSI Stochastic %D Stochastic %K MACD MACD Divergence MACD Signal DMI CCI Volatility Bollinger Upper Bollinger Mid Bollinger Lower
Date Name Description Type Symbol Company Name Location
Date UTC Location Action Description Object Severity User Action